Target intelligence / Profile preview

Californium-252 (252Cf)

Target
252Cf
Molecular classification
Radioisotope, Actinide, Other
01

Overview

Californium-252 is a synthetic radioactive isotope of the actinide series that serves as a potent source of neutrons (Wikipedia, 2024). It is not a biological target in the traditional pharmacological sense, such as a receptor or enzyme, but is instead utilized as a therapeutic radiation source in neutron brachytherapy for treating malignancies like cervical and prostate cancers (Maruyama et al., 1985; NIH, 2023). The isotope undergoes spontaneous fission, emitting high-energy neutrons with high linear energy transfer (LET) properties. These neutrons induce lethal double-strand DNA breaks in tumor cells, which are often more effective against radioresistant or hypoxic tumors compared to standard gamma or X-ray therapies (National Cancer Institute, 2023). However, the use of Californium-252 is limited by the requirement for specialized shielding and the potential for severe radiation-induced damage to surrounding healthy tissues (Radiobiology of Californium-252, 1986).

Other names
Cf-252Californium-252 isotopeCf-252 neutron source
02

Mechanism of action

Spontaneous fission resulting in the emission of high-energy neutrons that cause high linear energy transfer (LET) radiation damage and lethal double-strand DNA breaks in target cells.

03

Biological functions

Neutron emissionIonizing radiationCell deathOther
04

Disease associations

Cancer
05

Safety considerations

Radiation toxicityNeutron-induced healthy tissue damageSecondary malignanciesHandling and containment hazardsRegulatory compliance for radioactive materials

Beyond the preview

Go deeper on Californium-252 (252Cf).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Californium-252 (252Cf).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call